Cargando…

CHA2DS2VASc score predicts risk of end stage renal disease in patients with atrial fibrillation: Long-term follow-up study

BACKGROUND: End stage renal disease (ESRD) is an increasing worldwide epidemic disease. CHA2DS2-VASc score is a well-established predictor of cardiovascular outcome among atrial fibrillation (AF) patients. OBJECTIVE: The aim of this study was to test whether CHA2DS2-VASc score is a good predictor fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Pang-Shuo, Cheng, Jen-Fang, Chen, Jien-Jiun, Wu, Cho-Kai, Wang, Yi-Chih, Hwang, Juey-Jen, Tsai, Chia-Ti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984850/ https://www.ncbi.nlm.nih.gov/pubmed/36879966 http://dx.doi.org/10.1016/j.heliyon.2023.e13978

Ejemplares similares

Correlation Between CHA(2)DS(2)-VASc Score and Left Atrial Size in Patients With Atrial Fibrillation: A More Than 15-Year Prospective Follow-Up Study
por: Tsai, Chin-Feng, et al.
Publicado: (2021)

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS(2)/CHA(2)DS(2)VASc Score
por: Hung, Chen-Ying, et al.
Publicado: (2014)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Sodium‐Glucose Cotransporter‐2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation
por: Chang, Sheng‐Nan, et al.
Publicado: (2023)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive value of CHADS(2) and CHA(2)DS(2)-VASc scores for acute myocardial infarction in patients with atrial fibrillation
por: Pang, Hui, et al.
Publicado: (2017)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

The relationship of the serum endocan level with the CHA(2)DS(2)-VASc score in patients with paroxysmal atrial fibrillation
por: Ceyhun, Gökhan
Publicado: (2021)

Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
por: Tsiartas, Eirinaios, et al.
Publicado: (2023)

ACC/AHA Hypertension Guidelines and CHA(2)DS(2)-VASc Up-Scoring in Patients With Atrial Fibrillation
por: Pundi, Krishna, et al.
Publicado: (2023)

Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA(2)DS(2)‐VASc Score of 1 (Men) or 2 (Women)?
por: Hung, Yuan, et al.
Publicado: (2016)

Assessment of CHADS(2) and CHA(2)DS(2)-VASc scores in obstructive sleep apnea patients with atrial fibrillation
por: Szymanski, Filip M., et al.
Publicado: (2014)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA(2)DS(2)-VASc Score
por: Lin, Yu-Sheng, et al.
Publicado: (2018)

The CHA(2)DS(2)-VASc Score as a Predictor of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation
por: Uz, Omer, et al.
Publicado: (2014)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

Use of the CHA(2)DS(2)VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation
por: Atkinson, Charlotte, et al.
Publicado: (2017)

Can men with atrial fibrillation really rest easy with a CHA(2)DS(2)-VASc score of 0?
por: Cheng, Chen-Di, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score, cerebral small vessel disease, and frailty in older patients with atrial fibrillation
por: Choi, Jung-Yeon, et al.
Publicado: (2020)

Impact of timing of atrial fibrillation, CHA(2)DS(2)-VASc score and cancer therapeutics on mortality in oncology patients
por: Hussain, Muzna, et al.
Publicado: (2020)

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
por: ZHENG, Jian-Yong, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

CHADS(2) and CHA(2)DS(2)-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery
por: Yin, Liang, et al.
Publicado: (2015)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA(2)DS(2)-VASc Score in Anticoagulated Patients with Atrial Fibrillation
por: Carnevale, Roberto, et al.
Publicado: (2014)

The Validation of the ATRIA and CHA2DS2-Vasc Scores in Predicting Atrial Fibrillation after Coronary Artery Bypass Surgery
por: Uysal, Dinçer, et al.
Publicado: (2020)

Mortality Prediction of the CHA(2)DS(2)-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
por: Morrone, Doralisa, et al.
Publicado: (2020)

CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation
por: Wang, Bo-Yuan, et al.
Publicado: (2021)

Biomarkers, Clinical Variables, and the CHA(2)DS(2)-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients
por: Krisai, Philipp, et al.
Publicado: (2021)

Assessment of the CHA(2)DS(2)-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2021)

Silent cerebral infarcts in patients with atrial fibrillation: Clinical implications of an imaging-adjusted CHA(2)DS(2)-VASc score
por: Bretzman, John P., et al.
Publicado: (2022)

Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA(2)DS(2)‐VASc score of 0
por: Choi, Hyohun, et al.
Publicado: (2023)

Value of D-Dimer in Risk Stratification for Thromboembolism in Patients With Atrial Fibrillation and Low CHA2DS2-VASc Score
por: Chen, Po-Han, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

R(2(GFR))CHADS(2) and R(2(GFR))CHA(2)DS(2)VASc schemes improved the performance of CHADS(2) and CHA(2)DS(2)VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dc9gi2frh70qhjaa2fnnrsmbms